Header Logo

Connection

Angela Woodiwiss to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Angela Woodiwiss has written about Tumor Necrosis Factor-alpha.
Connection Strength

0,474
  1. The G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy. Cardiovasc J Afr. 2008 Sep-Oct; 19(5):254-8.
    View in: PubMed
    Score: 0,310
  2. Endotoxin-independent white cell cytokine production in haemodynamically stable patients with idiopathic dilated cardiomyopathy. Cardiovasc J S Afr. 2005 Sep-Oct; 16(5):260-5.
    View in: PubMed
    Score: 0,063
  3. Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis. PLoS One. 2020; 15(3):e0230657.
    View in: PubMed
    Score: 0,043
  4. Sustained white cell cytokine activation in idiopathic dilated cardiomyopathy despite haemodynamic improvement with medical therapy. Cardiovasc J S Afr. 2005 Jul-Aug; 16(4):200-4.
    View in: PubMed
    Score: 0,016
  5. C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2004 Oct; 6(6):731-4.
    View in: PubMed
    Score: 0,015
  6. Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation. 2004 Feb 17; 109(6):750-5.
    View in: PubMed
    Score: 0,014
  7. Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2002 Nov 15; 90(10):1118-22.
    View in: PubMed
    Score: 0,013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.